Christian Knackstedt

Associate professor

Dr Christian Knackstedt was born in in Giessen (Germany). After completing his secondary school (Gymnasium) in Münster, he started his medical training at the University of Münster, Germany. During his studies, he spent some time abroad in France, Switzerland, and the US and finally obtained his medical degree.

After an interim position at the Department of Cardiology, Herz- und Diabeteszentrum, Bad Oeynhausen, he soon moved to the University Hospital at the RWTH Aachen University where he pursued his formation as internist and cardiologist. Also, he succeeded in obtaining his German 'promotion' and later 'habilitation' besides passing the board examinations for internal medicine, cardiology and sport medicine. Gaining some more expertise in the field of sport cardiology as a senior physician at the Institute of Cardiology and Sports medicine, German Sport University Cologne, Cologne, Germany, he finally returned to his roots as a clinical cardiologist at Maastricht UMC+. He now holds a position as senior physician with an expertise in heart failure.

My research interest has always been the niche between heart failure and imaging/ mostly echocardiography. One of the topics I am currently interested in, is early detection of cardiac dysfunction. This goes hand in hand with the application of new echocardiographic techniques in the clinical practice. Also, I have been engaged and involved in research activities to improve therapy of heart failure by different means.

Department of Cardiology
Universiteitssingel 50, 6229 ER Maastricht
PO Box 616, 6200 MD Maastricht

  • 2021
    • Verdonschot, J. A. J., Henkens, M. T. H. M., Wang, P., Schummers, G., Raafs, A. G., Krapels, I. P. C., van Empel, V., Heymans, S. R. B., Brunner-La Rocca, H-P., & Knackstedt, C. (2021). A global longitudinal strain cut-off value to predict adverse outcomes in individuals with a normal ejection fraction. Esc heart failure, 8(5), 4343-4345. https://doi.org/10.1002/ehf2.13465
    • Moura, B., Aimo, A., Al-Mohammad, A., Flammer, A., Barberis, V., Bayes-Genis, A., Rocca, H. P. B. L., Fontes-Carvalho, R., Grapsa, J., Hulsmann, M., Ibrahim, N., Knackstedt, C., Januzzi, J. L., Lapinskas, T., Sarrias, A., Matskeplishvili, S., Meijers, W. C., Messroghli, D., Mueller, C., ... Richards, A. M. (2021). Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology. European journal of heart failure. https://doi.org/10.1002/ejhf.2339
    • Gingele, A. J., Brandts, L., Vossen, K., Knackstedt, C., Boyne, J., & Rocca, H. P. B. L. (2021). Prognostic value of signs and symptoms in heart failure patients using remote telemonitoring. Journal of Telemedicine and Telecare, [1357633X211039404]. https://doi.org/10.1177/1357633X211039404
    • Amin, H., Weerts, J., Brunner-La Rocca, H. P., Knackstedt, C., & Sanders-van Wijk, S. (2021). Future perspective of heart failure care: benefits and bottlenecks of artificial intelligence and eHealth. Future Cardiology, 17(6), 917-921. https://doi.org/10.2217/fca-2021-0008
    • Raafs, A. G., Verdonschot, J. A. J., Henkens, M. T. H. M., Adriaans, B. P., Wang, P., Derks, K., Abdul Hamid, M. A., Knackstedt, C., van Empel, V. P. M., Diez, J., Brunner-La Rocca, H-P., Brunner, H. G., Gonzalez, A., Bekkers, S. C. A. M., Heymans, S. R. B., & Hazebroek, M. R. (2021). The combination of carboxy-terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy - A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy. European journal of heart failure, 23(6), 933-944. https://doi.org/10.1002/ejhf.2201
    • Sanders-van Wijk, S., Barandiaran Aizpurua, A., Brunner-La Rocca, H-P., Henkens, M. T. H. M., Weerts, J., Knackstedt, C., Uszko-Lencer, N., Heymans, S., & van Empel, V. (2021). The HFA-PEFF and H2FPEF scores largely disagree in classifying patients with suspected heart failure with preserved ejection fraction. European journal of heart failure, 23(5), 838-840. https://doi.org/10.1002/ejhf.2019
    • Aizpurua, A. B., Sanders-van Wijk, S., Brunner-La Rocca, H. P., Henkens, M. T. H. M., Weerts, J., Spanjers, M. H. A., Knackstedt, C., & van Empel, V. P. M. (2021). Iron deficiency impacts prognosis but less exercise capacity in heart failure with preserved ejection fraction. Esc heart failure, 8(2), 1304-1313. https://doi.org/10.1002/ehf2.13204
    • van Stipdonk, A. M. W., Schretlen, S., Dohmen, W., Brunner-LaRocca, H. P., Knackstedt, C., & Vernooy, K. (2021). Development and implementation of a cardiac resynchronisation therapy care pathway: improved process and reduced resource use. BMJ Open Quality, 10(1), [e001072]. https://doi.org/10.1136/bmjoq-2020-001072
    • Hazebroek, M. R., Henkens, M. T. H. M., Raafs, A. G., Verdonschot, J. A. J., Merken, J. J., Dennert, R. M., Eurlings, C., Hamid, M. A. A., Wolffs, P. F. G., Winkens, B., Brunner-La Rocca, H. P., Knackstedt, C., van Paassen, P., van Empel, V. P. M., & Heymans, S. R. B. (2021). Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double-blind, randomized, placebo-controlled clinical trial. European journal of heart failure, 23(2), 302-309. https://doi.org/10.1002/ejhf.2082
  • 2020
    • Verdonschot, J. A. J., Merken, J. J., van Stipdonk, A. M. W., Pliger, P., Derks, K. W. J., Wang, P., Henkens, M. T. H. M., van Paassen, P., Hamid, M. A. A., van Empel, V. P. M., Knackstedt, C., Luermans, J. G. L. M., Crijns, H. J. G. M., Brunner-La Rocca, H-P., Brunner, H. G., Poelzl, G., Vernooy, K., Heymans, S. R. B., & Hazebroek, M. R. (2020). Cardiac Inflammation Impedes Response to Cardiac Resynchronization Therapy in Patients With Idiopathic Dilated Cardiomyopathy. Circulation-Arrhythmia and Electrophysiology, 13(11), 1311-1320. [008727]. https://doi.org/10.1161/circep.120.008727